Table 2.
Populations of patients evaluated for safety and efficacy of inVag® treatment
| Total number of patients | Patients using inVag | Patients using placebo | |
|---|---|---|---|
| Patients (randomized) | 160 (100%) | 86 (100%) | 74 (100%) |
| Safety evaluation (S) | 141 (88%) | 76 (88%) | 65 (88%) |
| Efficacy evaluation (E) | 112 (70%) | 61 (71%) | 51 (69%) |